Pattern of MRI brain in neuro- @entity146 XXXX . Effect of anti-phospholipid antibodies: A study at a tertiary care teaching hospital.

@entity1 @entity410 @entity146 @entity63 @entity75 @entity1252 @entity51 @entity1188 @entity194 @entity62 @entity10
OBJECTIVE: To compare the neuro-radiologic findings in @entity1252 ( @entity1252 ) @entity1 with and without antiphospholipid antibodies (aPL) in different neuro- @entity146 manifestations. METHODS: This cross-sectional comparative study was carried out at King Khalid University Hospital, a tertiary care teaching hospital, Riyadh, Saudi Arabia from June 2012 to January 2015. Ninety seven @entity1252 @entity1 with neuro- @entity146 manifestations were included in the study and divided into two groups. Group I (50 @entity1 ) @entity1252 with aPL and group II (47 @entity1 ) @entity1252 without aPL. We compared Demographic features, clinical manifestations and magnetic resonance imaging (MRI) brain findings. RESULTS: Demographic and clinical characteristics of two groups were similar. In Group-I, anticardiolipin antibodies (aCL) were most common (86%). In @entity1 with @entity10 , most of the @entity1 in Group-I had @entity62 ( @entity62 ) (50% vs 27%) while most of the @entity1 in Group-II had normal MRI brain (38% vs 73%). Similarly @entity62 were found more in Group-I @entity1 with @entity410 (60% vs 21%), while @entity63 / @entity1188 , @entity194 and normal MRI were found in Group-II. MRI brain in @entity1 with @entity51 and @entity146 were not much different in both the groups. CONCLUSION: We found no statistically significant differences in frequencies of @entity75 in @entity1252 @entity1 with and without aPL antibodies. Each of the three aPL may have a variable effect on the brain.
